Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasotestt vs Androgel in Male Hypogonadism
NCT03281187Phase 3Unknown
- Sponsor
- FBM-Pharma
- Start
- Jul 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of AndroForte in Hypogonadism, sponsored by FBM-Pharma. Status: unknown.
02
Drugs
AndroForte
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT03281187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03281187.